NEW YORK (GenomeWeb News) – RayBiotech said late Thursday that it has executed a master services agreement with Banner Sun Health Research Institute for the analysis of biomarkers of neurodegenerative disorders.

Under the agreement, RayBiotech will provide services for the analysis of biomarkers with a particular focus on ailments such as Alzheimer's and Parkinson diseases. The company's platform can be used to evaluate both the identity and quantity of biomarkers in a comprehensive, high-throughput manner, it said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: new gene linked to ocular coloboma, new statistical model for interrogating gene expression networks, and more.

With a new collection, PLOS highlights negative results it has published.

A pair of researchers examines political leanings and views on genomics, finding more of a role for optimism and pessimism in people's views.

The genome of the carnivorous bladderwort is smaller than many other plant genomes, but it still holds on to important genes.